Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Dopamine D1 | 16 | 2021 | 291 | 4.040 |
Why?
|
Cocaine | 13 | 2021 | 1007 | 2.660 |
Why?
|
Behavior, Animal | 16 | 2018 | 1881 | 2.450 |
Why?
|
Maternal Deprivation | 7 | 2018 | 48 | 2.310 |
Why?
|
Dopamine Uptake Inhibitors | 11 | 2021 | 312 | 2.140 |
Why?
|
Methylphenidate | 11 | 2018 | 473 | 2.040 |
Why?
|
Prefrontal Cortex | 20 | 2021 | 2148 | 1.990 |
Why?
|
Rats, Sprague-Dawley | 55 | 2021 | 8302 | 1.710 |
Why?
|
Dopamine | 21 | 2016 | 1591 | 1.700 |
Why?
|
Nucleus Accumbens | 15 | 2016 | 366 | 1.580 |
Why?
|
Cues | 6 | 2021 | 873 | 1.550 |
Why?
|
Receptors, Dopamine D2 | 15 | 2017 | 475 | 1.450 |
Why?
|
Exploratory Behavior | 4 | 2021 | 270 | 1.370 |
Why?
|
Behavior, Addictive | 5 | 2022 | 462 | 1.290 |
Why?
|
Rats | 60 | 2021 | 24273 | 1.240 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 13 | 2017 | 3658 | 1.190 |
Why?
|
Parvalbumins | 4 | 2018 | 250 | 1.140 |
Why?
|
Sex Characteristics | 11 | 2018 | 2586 | 1.090 |
Why?
|
Stress, Psychological | 13 | 2022 | 4245 | 1.090 |
Why?
|
Cocaine-Related Disorders | 3 | 2015 | 460 | 1.050 |
Why?
|
Extinction, Psychological | 4 | 2015 | 376 | 1.040 |
Why?
|
Central Nervous System Stimulants | 12 | 2017 | 1148 | 1.020 |
Why?
|
Helplessness, Learned | 4 | 2018 | 28 | 0.890 |
Why?
|
Brain | 24 | 2022 | 26413 | 0.880 |
Why?
|
Neostriatum | 9 | 2002 | 250 | 0.840 |
Why?
|
Depression | 8 | 2018 | 7767 | 0.830 |
Why?
|
Child Abuse | 6 | 2022 | 1030 | 0.780 |
Why?
|
Motor Activity | 9 | 2016 | 2714 | 0.780 |
Why?
|
Animals, Newborn | 12 | 2017 | 2726 | 0.760 |
Why?
|
Substance-Related Disorders | 7 | 2021 | 4259 | 0.740 |
Why?
|
Corpus Striatum | 12 | 2017 | 1220 | 0.680 |
Why?
|
Maternal Behavior | 2 | 2013 | 311 | 0.670 |
Why?
|
Guanfacine | 1 | 2018 | 51 | 0.650 |
Why?
|
Adolescent Development | 3 | 2014 | 278 | 0.650 |
Why?
|
Reward | 4 | 2016 | 941 | 0.620 |
Why?
|
Antidepressive Agents, Tricyclic | 3 | 2015 | 434 | 0.620 |
Why?
|
Drug-Seeking Behavior | 1 | 2017 | 48 | 0.600 |
Why?
|
Receptor, trkB | 1 | 2018 | 125 | 0.590 |
Why?
|
Gonadal Hormones | 1 | 2016 | 29 | 0.570 |
Why?
|
Child Abuse, Sexual | 3 | 2009 | 383 | 0.560 |
Why?
|
Animals | 74 | 2022 | 168788 | 0.550 |
Why?
|
Motivation | 5 | 2018 | 1971 | 0.540 |
Why?
|
Receptors, Corticotropin-Releasing Hormone | 1 | 2016 | 87 | 0.530 |
Why?
|
Receptors, GABA | 1 | 2017 | 288 | 0.520 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2017 | 604 | 0.520 |
Why?
|
Amygdala | 3 | 2018 | 1315 | 0.510 |
Why?
|
Receptors, Dopamine | 3 | 2016 | 295 | 0.500 |
Why?
|
Ventral Tegmental Area | 1 | 2016 | 142 | 0.500 |
Why?
|
Aging | 20 | 2015 | 8661 | 0.490 |
Why?
|
Mothers | 2 | 2016 | 2165 | 0.490 |
Why?
|
Clomipramine | 4 | 2015 | 54 | 0.490 |
Why?
|
Impulsive Behavior | 4 | 2018 | 316 | 0.470 |
Why?
|
Obsessive-Compulsive Disorder | 2 | 2015 | 1444 | 0.470 |
Why?
|
Binge-Eating Disorder | 1 | 2015 | 137 | 0.460 |
Why?
|
Cyclooxygenase 2 | 2 | 2017 | 611 | 0.450 |
Why?
|
Memory, Short-Term | 2 | 2017 | 975 | 0.420 |
Why?
|
Psychotropic Drugs | 2 | 2011 | 894 | 0.420 |
Why?
|
Age Factors | 18 | 2018 | 18367 | 0.410 |
Why?
|
Narcotics | 2 | 2010 | 343 | 0.410 |
Why?
|
Risk-Taking | 2 | 2016 | 986 | 0.410 |
Why?
|
Locomotion | 2 | 2014 | 378 | 0.410 |
Why?
|
Hyperthyroidism | 1 | 2014 | 295 | 0.410 |
Why?
|
Sexual Development | 1 | 2011 | 34 | 0.390 |
Why?
|
Depressive Disorder | 3 | 2017 | 3750 | 0.390 |
Why?
|
Neuropharmacology | 1 | 2011 | 21 | 0.390 |
Why?
|
Resilience, Psychological | 1 | 2018 | 675 | 0.370 |
Why?
|
gamma-Aminobutyric Acid | 2 | 2017 | 1123 | 0.370 |
Why?
|
Receptors, Dopamine D3 | 2 | 2008 | 110 | 0.370 |
Why?
|
Fluoxetine | 2 | 2013 | 749 | 0.370 |
Why?
|
Child of Impaired Parents | 1 | 2014 | 455 | 0.360 |
Why?
|
Disease Models, Animal | 10 | 2018 | 18027 | 0.360 |
Why?
|
Dizocilpine Maleate | 2 | 2008 | 176 | 0.360 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2013 | 503 | 0.360 |
Why?
|
Sex Factors | 9 | 2021 | 10396 | 0.350 |
Why?
|
Mental Processes | 1 | 2011 | 249 | 0.350 |
Why?
|
Hypothyroidism | 1 | 2014 | 659 | 0.330 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2014 | 615 | 0.330 |
Why?
|
Stress, Physiological | 2 | 2008 | 1404 | 0.330 |
Why?
|
Frontal Lobe | 2 | 2012 | 1407 | 0.320 |
Why?
|
Developmental Disabilities | 2 | 2008 | 1456 | 0.310 |
Why?
|
Opioid-Related Disorders | 1 | 2022 | 2065 | 0.310 |
Why?
|
Sexual Maturation | 3 | 2011 | 265 | 0.300 |
Why?
|
Male | 59 | 2021 | 350027 | 0.300 |
Why?
|
Anxiety | 5 | 2015 | 4297 | 0.300 |
Why?
|
Oxidopamine | 3 | 2016 | 169 | 0.300 |
Why?
|
Conditioning, Classical | 2 | 2008 | 366 | 0.300 |
Why?
|
Association Learning | 2 | 2008 | 224 | 0.290 |
Why?
|
Self Administration | 2 | 2018 | 386 | 0.290 |
Why?
|
Dopamine Agonists | 6 | 2010 | 355 | 0.280 |
Why?
|
Maze Learning | 3 | 2009 | 478 | 0.280 |
Why?
|
Neurobiology | 2 | 2006 | 121 | 0.270 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2008 | 449 | 0.260 |
Why?
|
Dose-Response Relationship, Drug | 15 | 2018 | 10949 | 0.260 |
Why?
|
Nervous System | 1 | 2008 | 554 | 0.260 |
Why?
|
Lentivirus | 2 | 2021 | 501 | 0.250 |
Why?
|
Female | 45 | 2021 | 380197 | 0.250 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 4 | 2010 | 54 | 0.240 |
Why?
|
Apomorphine | 2 | 1994 | 150 | 0.240 |
Why?
|
Functional Laterality | 2 | 2002 | 2290 | 0.240 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 2012 | 895 | 0.230 |
Why?
|
Potassium | 4 | 1996 | 1336 | 0.220 |
Why?
|
Adolescent | 18 | 2022 | 85759 | 0.220 |
Why?
|
Biological Factors | 2 | 2020 | 164 | 0.220 |
Why?
|
Mental Disorders | 3 | 2016 | 6601 | 0.220 |
Why?
|
Biogenic Monoamines | 1 | 2002 | 50 | 0.210 |
Why?
|
Microdialysis | 7 | 2010 | 158 | 0.210 |
Why?
|
Nicotine | 2 | 2020 | 681 | 0.210 |
Why?
|
Cyclooxygenase 2 Inhibitors | 2 | 2017 | 320 | 0.210 |
Why?
|
Conditioning, Operant | 3 | 2015 | 313 | 0.210 |
Why?
|
Benzodiazepines | 1 | 2008 | 1101 | 0.200 |
Why?
|
Human Development | 1 | 2003 | 124 | 0.200 |
Why?
|
Concept Formation | 1 | 2003 | 158 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-fos | 2 | 2001 | 575 | 0.200 |
Why?
|
Amphetamine-Related Disorders | 1 | 2001 | 67 | 0.200 |
Why?
|
Second Messenger Systems | 1 | 2002 | 206 | 0.200 |
Why?
|
Nerve Endings | 2 | 1998 | 109 | 0.200 |
Why?
|
Hippocampus | 4 | 2011 | 3676 | 0.190 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 2279 | 0.190 |
Why?
|
Social Isolation | 2 | 2018 | 365 | 0.190 |
Why?
|
Adaptation, Physiological | 2 | 2004 | 1312 | 0.180 |
Why?
|
Interneurons | 2 | 2011 | 577 | 0.180 |
Why?
|
Neurons | 5 | 2016 | 9335 | 0.180 |
Why?
|
Milk | 2 | 1993 | 450 | 0.180 |
Why?
|
Sulpiride | 2 | 1996 | 17 | 0.180 |
Why?
|
Glutamic Acid | 2 | 2016 | 1169 | 0.180 |
Why?
|
Corpus Callosum | 1 | 2004 | 737 | 0.170 |
Why?
|
Synapses | 2 | 2008 | 1729 | 0.170 |
Why?
|
Raphe Nuclei | 1 | 1999 | 104 | 0.170 |
Why?
|
Child | 18 | 2022 | 77679 | 0.170 |
Why?
|
Cerebrovascular Circulation | 2 | 2010 | 2732 | 0.170 |
Why?
|
Psychopathology | 1 | 2022 | 409 | 0.160 |
Why?
|
Analysis of Variance | 6 | 2008 | 6367 | 0.160 |
Why?
|
Tyrosine 3-Monooxygenase | 2 | 2016 | 375 | 0.160 |
Why?
|
Ovariectomy | 2 | 2016 | 661 | 0.160 |
Why?
|
Serotonin | 2 | 1999 | 1023 | 0.160 |
Why?
|
Receptors, Neurotransmitter | 2 | 2016 | 178 | 0.160 |
Why?
|
Genetic Vectors | 2 | 2021 | 3420 | 0.160 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2018 | 87 | 0.160 |
Why?
|
Cyclic AMP | 1 | 2002 | 1471 | 0.160 |
Why?
|
Adolescent Behavior | 2 | 2020 | 1151 | 0.150 |
Why?
|
Autoradiography | 4 | 2003 | 749 | 0.150 |
Why?
|
Dopamine Antagonists | 5 | 2008 | 296 | 0.150 |
Why?
|
Tetrodotoxin | 2 | 1998 | 259 | 0.150 |
Why?
|
Cerebral Cortex | 3 | 2012 | 5709 | 0.150 |
Why?
|
Catecholamines | 1 | 1998 | 387 | 0.150 |
Why?
|
Tetrahydronaphthalenes | 1 | 1997 | 89 | 0.150 |
Why?
|
Quinpirole | 5 | 2010 | 33 | 0.150 |
Why?
|
Brain Chemistry | 3 | 2008 | 982 | 0.150 |
Why?
|
Limbic System | 1 | 1999 | 426 | 0.140 |
Why?
|
Amphetamines | 1 | 2017 | 148 | 0.140 |
Why?
|
Synaptophysin | 2 | 2008 | 141 | 0.140 |
Why?
|
Random Allocation | 2 | 2013 | 2427 | 0.140 |
Why?
|
Risk | 1 | 2008 | 9685 | 0.140 |
Why?
|
Consummatory Behavior | 1 | 2015 | 6 | 0.130 |
Why?
|
Neuronal Plasticity | 1 | 2004 | 1422 | 0.130 |
Why?
|
Tryptophan Hydroxylase | 1 | 2016 | 89 | 0.130 |
Why?
|
Neuroimmunomodulation | 1 | 2017 | 157 | 0.130 |
Why?
|
Estrogens | 1 | 2002 | 1565 | 0.130 |
Why?
|
Bupropion | 1 | 1997 | 303 | 0.130 |
Why?
|
Receptors, Opioid, kappa | 2 | 1993 | 144 | 0.130 |
Why?
|
Spatial Behavior | 1 | 2015 | 90 | 0.130 |
Why?
|
Sucrose | 1 | 2015 | 164 | 0.120 |
Why?
|
Species Specificity | 2 | 2011 | 2480 | 0.120 |
Why?
|
RNA, Messenger | 3 | 2016 | 13036 | 0.120 |
Why?
|
Adrenergic Agents | 1 | 2014 | 70 | 0.120 |
Why?
|
Pregnancy | 7 | 2014 | 29142 | 0.120 |
Why?
|
Fetal Movement | 1 | 1993 | 21 | 0.110 |
Why?
|
Reflex, Stretch | 1 | 1993 | 24 | 0.110 |
Why?
|
Sucking Behavior | 1 | 1993 | 28 | 0.110 |
Why?
|
Saliva | 1 | 2017 | 809 | 0.110 |
Why?
|
Denmark | 2 | 2014 | 738 | 0.110 |
Why?
|
Time Factors | 9 | 2014 | 40063 | 0.110 |
Why?
|
Humans | 32 | 2022 | 744220 | 0.110 |
Why?
|
Central Nervous System Depressants | 1 | 2014 | 167 | 0.110 |
Why?
|
Stereotyped Behavior | 1 | 1993 | 136 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 8 | 2021 | 35423 | 0.100 |
Why?
|
Dietary Sucrose | 1 | 2014 | 247 | 0.100 |
Why?
|
Dopamine Agents | 2 | 2008 | 189 | 0.100 |
Why?
|
Nicotinic Agonists | 1 | 2014 | 271 | 0.100 |
Why?
|
Nitrobenzenes | 1 | 2011 | 65 | 0.100 |
Why?
|
Testosterone | 1 | 2002 | 2411 | 0.100 |
Why?
|
Depressive Disorder, Major | 1 | 2009 | 4645 | 0.100 |
Why?
|
Receptor, Serotonin, 5-HT2C | 1 | 2010 | 44 | 0.100 |
Why?
|
Space Perception | 1 | 2014 | 475 | 0.090 |
Why?
|
Environment | 3 | 2008 | 1124 | 0.090 |
Why?
|
Nesting Behavior | 1 | 2009 | 17 | 0.090 |
Why?
|
Propylamines | 1 | 2010 | 165 | 0.090 |
Why?
|
Microinjections | 1 | 2010 | 327 | 0.090 |
Why?
|
Thyroid Gland | 1 | 2016 | 1172 | 0.090 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2010 | 189 | 0.080 |
Why?
|
Birth Order | 1 | 2009 | 95 | 0.080 |
Why?
|
Neurotransmitter Agents | 2 | 2011 | 647 | 0.080 |
Why?
|
Drugs, Investigational | 1 | 2011 | 214 | 0.080 |
Why?
|
Amphetamine | 3 | 2010 | 225 | 0.080 |
Why?
|
Injections, Intraperitoneal | 1 | 2009 | 424 | 0.080 |
Why?
|
Extracellular Space | 1 | 2010 | 594 | 0.080 |
Why?
|
Hypothalamo-Hypophyseal System | 3 | 2008 | 703 | 0.080 |
Why?
|
Drug Interactions | 3 | 2008 | 1458 | 0.080 |
Why?
|
Stereoisomerism | 1 | 2009 | 625 | 0.080 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2008 | 117 | 0.080 |
Why?
|
Norepinephrine | 1 | 2010 | 909 | 0.080 |
Why?
|
Pituitary-Adrenal System | 2 | 2008 | 553 | 0.070 |
Why?
|
Ethanol | 1 | 2014 | 1342 | 0.070 |
Why?
|
Levodopa | 2 | 1998 | 219 | 0.070 |
Why?
|
Dietary Fats | 1 | 2015 | 2017 | 0.070 |
Why?
|
Substantia Nigra | 1 | 2008 | 353 | 0.070 |
Why?
|
Avoidance Learning | 1 | 2008 | 233 | 0.070 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 3 | 1998 | 64 | 0.070 |
Why?
|
Learning | 1 | 2016 | 1713 | 0.070 |
Why?
|
Infant, Newborn | 4 | 2014 | 25618 | 0.070 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 1999 | 1574 | 0.070 |
Why?
|
Fetus | 1 | 1993 | 1880 | 0.070 |
Why?
|
Early Diagnosis | 1 | 2011 | 1184 | 0.070 |
Why?
|
Haplorhini | 1 | 2006 | 552 | 0.070 |
Why?
|
Administration, Oral | 2 | 2009 | 3913 | 0.060 |
Why?
|
Siblings | 1 | 2009 | 854 | 0.060 |
Why?
|
Medial Forebrain Bundle | 1 | 2005 | 45 | 0.060 |
Why?
|
Hormones | 1 | 2008 | 887 | 0.060 |
Why?
|
Adaptation, Psychological | 1 | 2015 | 2576 | 0.060 |
Why?
|
Young Adult | 3 | 2022 | 56436 | 0.060 |
Why?
|
Blotting, Western | 2 | 2012 | 5180 | 0.060 |
Why?
|
Demography | 1 | 2009 | 1656 | 0.060 |
Why?
|
Adult | 8 | 2022 | 214035 | 0.060 |
Why?
|
Memory Disorders | 1 | 2011 | 1184 | 0.060 |
Why?
|
Social Environment | 1 | 2008 | 1023 | 0.060 |
Why?
|
Nerve Net | 2 | 2016 | 2175 | 0.060 |
Why?
|
Long-Term Potentiation | 1 | 2005 | 293 | 0.060 |
Why?
|
Salicylamides | 2 | 2005 | 33 | 0.060 |
Why?
|
Radioligand Assay | 1 | 2003 | 379 | 0.050 |
Why?
|
Swimming | 1 | 2003 | 206 | 0.050 |
Why?
|
Immobilization | 1 | 2003 | 236 | 0.050 |
Why?
|
Reference Values | 2 | 2004 | 4982 | 0.050 |
Why?
|
Cohort Studies | 2 | 2016 | 40559 | 0.050 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2009 | 1953 | 0.050 |
Why?
|
Salmonella Food Poisoning | 1 | 2001 | 14 | 0.050 |
Why?
|
Age of Onset | 1 | 2009 | 3270 | 0.050 |
Why?
|
Euphoria | 1 | 2001 | 67 | 0.050 |
Why?
|
Forecasting | 1 | 2011 | 2949 | 0.050 |
Why?
|
Sulfonamides | 1 | 2011 | 1940 | 0.050 |
Why?
|
Salmonella enterica | 1 | 2001 | 75 | 0.050 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2014 | 2408 | 0.050 |
Why?
|
Child, Preschool | 5 | 2017 | 40992 | 0.050 |
Why?
|
Feeding Behavior | 1 | 2014 | 3188 | 0.050 |
Why?
|
Calcium | 1 | 1994 | 5757 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39045 | 0.050 |
Why?
|
Memory | 1 | 2010 | 2174 | 0.050 |
Why?
|
Orchiectomy | 1 | 2002 | 466 | 0.050 |
Why?
|
Regional Blood Flow | 2 | 2016 | 1525 | 0.040 |
Why?
|
Receptors, AMPA | 1 | 2002 | 331 | 0.040 |
Why?
|
Residence Characteristics | 1 | 2009 | 2050 | 0.040 |
Why?
|
Gastroenteritis | 1 | 2001 | 245 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12355 | 0.040 |
Why?
|
Salmonella typhimurium | 1 | 2001 | 351 | 0.040 |
Why?
|
Weaning | 1 | 1999 | 105 | 0.040 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2002 | 514 | 0.040 |
Why?
|
Infant | 3 | 2014 | 35129 | 0.040 |
Why?
|
Antidepressive Agents | 1 | 2011 | 2839 | 0.040 |
Why?
|
Homovanillic Acid | 2 | 1998 | 75 | 0.040 |
Why?
|
Clorgyline | 1 | 1997 | 14 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 8950 | 0.040 |
Why?
|
Selegiline | 1 | 1997 | 31 | 0.040 |
Why?
|
Regression Analysis | 1 | 2008 | 6461 | 0.040 |
Why?
|
Carbolines | 1 | 1999 | 265 | 0.040 |
Why?
|
Kinetics | 2 | 1996 | 6474 | 0.040 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 1997 | 158 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2008 | 6037 | 0.040 |
Why?
|
Neurotoxins | 1 | 1998 | 237 | 0.040 |
Why?
|
Reaction Time | 1 | 2003 | 2102 | 0.040 |
Why?
|
Psychology, Experimental | 1 | 1996 | 5 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 3617 | 0.040 |
Why?
|
Risk Assessment | 1 | 2017 | 23337 | 0.030 |
Why?
|
Akathisia, Drug-Induced | 1 | 1995 | 67 | 0.030 |
Why?
|
Incidence | 1 | 2014 | 20945 | 0.030 |
Why?
|
Disease Progression | 2 | 2011 | 13280 | 0.030 |
Why?
|
Models, Animal | 1 | 2002 | 2171 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2003 | 1424 | 0.030 |
Why?
|
Acridines | 1 | 1994 | 19 | 0.030 |
Why?
|
Parkinson Disease | 1 | 2008 | 2776 | 0.030 |
Why?
|
Ergolines | 1 | 1994 | 61 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 4044 | 0.030 |
Why?
|
Nerve Tissue Proteins | 3 | 2008 | 4465 | 0.030 |
Why?
|
Tissue Distribution | 1 | 1998 | 2335 | 0.030 |
Why?
|
Nerve Degeneration | 1 | 1998 | 748 | 0.030 |
Why?
|
Chemoreceptor Cells | 1 | 1993 | 86 | 0.030 |
Why?
|
Taste Buds | 1 | 1993 | 25 | 0.030 |
Why?
|
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 1993 | 24 | 0.030 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 2 | 2010 | 422 | 0.030 |
Why?
|
Dialysis | 1 | 1992 | 75 | 0.030 |
Why?
|
Inflammation | 1 | 2012 | 10634 | 0.030 |
Why?
|
Inpatients | 1 | 2004 | 2518 | 0.030 |
Why?
|
Receptors, Opioid, mu | 1 | 1993 | 182 | 0.030 |
Why?
|
Long-Term Care | 1 | 2016 | 607 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9438 | 0.030 |
Why?
|
Infusions, Parenteral | 1 | 1992 | 415 | 0.030 |
Why?
|
Drug Tolerance | 1 | 1994 | 376 | 0.030 |
Why?
|
Membrane Transport Proteins | 1 | 1997 | 1028 | 0.030 |
Why?
|
Body Weight | 1 | 2002 | 4666 | 0.020 |
Why?
|
Models, Neurological | 1 | 1999 | 1775 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15538 | 0.020 |
Why?
|
Pyrrolidines | 1 | 1993 | 342 | 0.020 |
Why?
|
Fear | 1 | 1999 | 1439 | 0.020 |
Why?
|
Phenanthridines | 1 | 2010 | 51 | 0.020 |
Why?
|
Child Development | 1 | 2002 | 2223 | 0.020 |
Why?
|
Thalamus | 1 | 2016 | 1024 | 0.020 |
Why?
|
Gyrus Cinguli | 1 | 2016 | 1091 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2016 | 63119 | 0.020 |
Why?
|
Brain Mapping | 1 | 2005 | 6671 | 0.020 |
Why?
|
Mice | 2 | 2015 | 81178 | 0.020 |
Why?
|
Microdissection | 1 | 2008 | 152 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2505 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2009 | 77426 | 0.020 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2003 | 4266 | 0.020 |
Why?
|
Psychotic Disorders | 1 | 2003 | 3046 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2001 | 11368 | 0.020 |
Why?
|
Antimalarials | 1 | 1994 | 907 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2012 | 1200 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2012 | 972 | 0.020 |
Why?
|
Risk Factors | 1 | 2014 | 72280 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 1997 | 3769 | 0.020 |
Why?
|
Analgesics | 1 | 1993 | 1040 | 0.020 |
Why?
|
Dextroamphetamine | 2 | 1996 | 129 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3871 | 0.020 |
Why?
|
Self Stimulation | 1 | 2005 | 55 | 0.020 |
Why?
|
Gestational Age | 1 | 1993 | 3493 | 0.020 |
Why?
|
Carrier Proteins | 1 | 1997 | 5021 | 0.010 |
Why?
|
Receptors, Dopamine D4 | 1 | 2004 | 171 | 0.010 |
Why?
|
Ion Channels | 1 | 2008 | 1056 | 0.010 |
Why?
|
Cesarean Section | 1 | 1992 | 1365 | 0.010 |
Why?
|
Ferric Compounds | 1 | 2005 | 374 | 0.010 |
Why?
|
Cytoskeleton | 1 | 2008 | 1185 | 0.010 |
Why?
|
Attention | 2 | 2004 | 2399 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2012 | 3201 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2016 | 12035 | 0.010 |
Why?
|
Benzazepines | 1 | 2004 | 326 | 0.010 |
Why?
|
Electroencephalography | 1 | 1997 | 6150 | 0.010 |
Why?
|
Serotyping | 1 | 2001 | 338 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4752 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3921 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2005 | 1770 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2008 | 1860 | 0.010 |
Why?
|
Cell Survival | 1 | 2008 | 5881 | 0.010 |
Why?
|
Pyrroles | 1 | 2004 | 1143 | 0.010 |
Why?
|
Parkinson Disease, Secondary | 1 | 1998 | 126 | 0.010 |
Why?
|
Putamen | 1 | 1998 | 291 | 0.010 |
Why?
|
Life Change Events | 1 | 2002 | 938 | 0.010 |
Why?
|
Biological Evolution | 1 | 2003 | 1076 | 0.010 |
Why?
|
Caudate Nucleus | 1 | 1998 | 393 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 29050 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2004 | 1901 | 0.010 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 1997 | 322 | 0.010 |
Why?
|
Cattle | 1 | 2001 | 3922 | 0.010 |
Why?
|
Mitochondria | 1 | 2008 | 3520 | 0.010 |
Why?
|
Habituation, Psychophysiologic | 1 | 1996 | 154 | 0.010 |
Why?
|
Aotus trivirgatus | 1 | 1994 | 37 | 0.010 |
Why?
|
Videotape Recording | 1 | 1996 | 350 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2002 | 1826 | 0.010 |
Why?
|
Oxygen | 1 | 2005 | 4187 | 0.010 |
Why?
|
Pyridines | 1 | 2004 | 2822 | 0.010 |
Why?
|
Apoptosis | 1 | 2008 | 9728 | 0.010 |
Why?
|
Swine | 1 | 2001 | 5940 | 0.010 |
Why?
|
Phenotype | 1 | 2008 | 16365 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 12075 | 0.010 |
Why?
|
Drug Resistance | 1 | 1994 | 1608 | 0.000 |
Why?
|
Malaria, Falciparum | 1 | 1994 | 1077 | 0.000 |
Why?
|
Plasmodium falciparum | 1 | 1994 | 1732 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2008 | 57768 | 0.000 |
Why?
|
Software | 1 | 1996 | 4442 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1997 | 7908 | 0.000 |
Why?
|
Aged | 1 | 2008 | 163253 | 0.000 |
Why?
|